Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Insurance Press Releases.
Press releases published on October 6, 2025
Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue of US$21.9 million on Ryoncil® (remestemcel-L-rknd) sales for the …
AEG Signs First-Of-Its-Kind Renewable Energy Agreement To Power UK Venues
London, UK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- AEG Europe, the European subsidiary of global sports and live entertainment leader AEG, has today announced a landmark agreement that will make its UK venues the first in the industry to run on the country’s …
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Fraud Lawsuit – UNCY
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between March 29, 2024 and June 27, 2025, both dates inclusive (the “Class …
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition
Carlsbad, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced a series of key leadership and governance changes aimed at strengthening its executive team, enhancing financial transparency, and …
AlphaGen Intelligence Corp. Announces Securities for Debt Settlement Transaction
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Oct. 06, 2025 (GLOBE NEWSWIRE) -- AlphaGen Intelligence Corp. (CSE: AIC | FSE: G4G) (“AlphaGen” or the “Company”) announces that …
New Leadership to Drive Healthy Jeena Sikho's Clinical Expansion into Physiotherapy and Sleep Care
Rajiv Kapoor joins as President of New Initiatives to augment the Leadership at Healthy Jeena Sikho DELHI, NOIDA, GURGAON, LUCKNOW, JAIPUR, CHANDIGARH, PUNJAB, INDIA, October 6, 2025 /EINPresswire.com/ -- Industry veteran Rajiv Kapoor joins as President …
Bombardier Completes Redemption for All of its 7.125% Senior Notes due 2026 and Partial Redemption for US$83,711,000 of its 7.875% Senior Notes due 2027
MONTRÉAL, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has redeemed all remaining outstanding US$166,289,000 aggregate principal amount of its 7.125% Senior Notes due 2026 (the “2026 Notes”) and US$83,711,000 …
Bombardier mène à bien le rachat de la totalité de ses billets de premier rang 7,125 % échéant en 2026 et le rachat partiel de ses billets de premier rang 7,875 % échéant en 2027 d’un capital de 83 711 000 $ US
MONTRÉAL, 06 oct. 2025 (GLOBE NEWSWIRE) -- Bombardier Inc. (« Bombardier ») a annoncé aujourd’hui qu’elle avait racheté la totalité de ses billets de premier rang 7,125 % échéant en 2026 (les « billets de 2026 ») restants en circulation d’un capital global …
Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
- Robust improvement demonstrated across diverse set of clinical measures - - Patient-reported outcomes support clinical meaningfulness of improvements in function and strength - - Meaningful improvements in overall disease burden reported by both patients …
Savara Inc. INVESTOR ALERT: Kirby McInerney LLP Reminds Savara Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- If you have suffered a loss on your Savara Inc. (“Savara” or the “Company”) (NASDAQ:SVRA) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact …
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
CELEBRATION, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that the Company has …
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
SAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a …
Brompton Split Banc Corp. Announces Class A Share Split and an Increase to Total Distributions
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- (TSX: SBC, SBC.PR.A) Brompton Split Banc Corp. (the “Fund”) is pleased to announce its intention to complete a stock split …
AGF Reports September 2025 Assets Under Management and Fee-Earning Assets
TORONTO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- AGF Management Limited reported total assets under management (AUM) and fee-earning assets1 of $59.0 billion as at September 30, 2025. AUM ($ billions) September 30, 2025 August 31, 2025 % Change Month-Over- …
AGF déclare le total de son actif géré et de ses actifs donnant droit à des commissions pour septembre 2025
TORONTO, 06 oct. 2025 (GLOBE NEWSWIRE) -- La Société de Gestion AGF Limitée (« AGF ») a déclaré un actif géré global, ainsi que des actifs donnant droit à des commissions1 totalisant 59,0 milliards $, au 30 septembre 2025. Actif géré (en …
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
Châtillon, France, October 6, 2025 DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company”), a …